Kudialis S J, Wirth R K
CRNA. 1995 Feb;6(1):26-30.
The search for an ideal combination of agents for labor epidural anesthesia has become a focus of current research studies. This study was performed to determine if a combination of sufentanil with bupivacaine would show superior analgesia and fewer side effects when compared with an equipotent combination of fentanyl with bupivacaine in continuous labor epidurals. After the approval of the Human Investigations Committee and written consent from the subjects, 54 parturients were assigned to receive one of two epidural drug combinations in a randomized double-blind design. Group S received a bolus of 10 mL of 2 micrograms/mL of sufentanil in 0.125% bupivacaine followed by an infusion of 0.4 micrograms/mL of sufentanil in 0.125% bupivacaine. Group F received a bolus of 10 mL of 10 micrograms/mL of fentanyl in 0.125% bupivacaine followed by an infusion of 2 micrograms/mL of fentanyl in 0.125% bupivacaine. Subsequent doses of 5 mL of 0.125% bupivacaine plain were given for inadequate analgesia per parturient request. Instrumentation included a visual analogue scale (VAS) for pain measurement and rating scales for side effects. Before the initial bolus, a baseline pain score was obtained. Pain scores and side effects were assessed at 30 minutes, 60 minutes, and hourly until delivery. Maternal satisfaction and apgar scores were recorded after delivery. There were no statistically significant differences found in VAS scores or requirement for epidural top-up injections between the two groups. Demographics, side effects, apgar scores, and maternal satisfaction scores were also comparable. Both sufentanil and fentanyl with bupivacaine provide comparably safe and satisfactory analgesia for labor epidural anesthesia.
寻找用于分娩硬膜外麻醉的理想药物组合已成为当前研究的重点。本研究旨在确定与等效剂量的芬太尼联合布比卡因用于持续分娩硬膜外麻醉相比,舒芬太尼联合布比卡因是否能提供更好的镇痛效果且副作用更少。经人类研究委员会批准并获得受试者书面同意后,54名产妇被随机双盲设计分为两组,分别接受两种硬膜外药物组合之一。S组先给予10 mL含2微克/毫升舒芬太尼的0.125%布比卡因推注,随后给予含0.4微克/毫升舒芬太尼的0.125%布比卡因持续输注。F组先给予10 mL含10微克/毫升芬太尼的0.125%布比卡因推注,随后给予含2微克/毫升芬太尼的0.125%布比卡因持续输注。根据每位产妇的要求,若镇痛效果不佳,则追加5 mL单纯0.125%布比卡因。测量工具包括用于疼痛测量的视觉模拟量表(VAS)和副作用评分量表。在首次推注前获得基线疼痛评分。在30分钟、60分钟时以及每小时直至分娩时评估疼痛评分和副作用。分娩后记录产妇满意度和阿氏评分。两组之间在VAS评分或硬膜外追加注射需求方面未发现统计学显著差异。人口统计学特征、副作用、阿氏评分和产妇满意度评分也具有可比性。舒芬太尼和芬太尼联合布比卡因用于分娩硬膜外麻醉时,镇痛效果相当安全且令人满意。